PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9764005

Caring by degrees.

C Ward
View original source ↗Export metadata ↓

Abstract

Caring is synonymous with nursing and, regardless of the culture, race, lifestyle or sexuality of clients, nurses should care for all clients. However, the emergence of HIV/AIDS brought a new and quite different challenge to nurses with regard to willingness to care. Some nurses expressed a negative attitude toward, and reluctance to care for, those clients with HIV/AIDS, mainly due to fear of contagion based on ignorance about the disease. The purpose of this cross-sectional study was firstly to determine if there were differences in attitudes toward caring for clients with HIV/AIDS in the three different at-risk groups (homosexuals, intravenous drug users and haemophiliacs), as expressed by nursing students at the beginning (Semester 1) and at the end (Semester 7) of a three-and-a-half-year nursing degree programme. The second determination was whether or not there were differences between the two groups of students regarding their knowledge of HIV/AIDS. Data results indicated no significant difference between the two groups of students in regard to caring attitude towards members of the at-risk groups and knowledge of AIDS. This paper discusses the implications of the research findings for nursing and further research.

Explore related subjects

Acquired Immunodeficiency SyndromeAdultAttitude of Health PersonnelCross-Sectional StudiesEducation, Nursing, BaccalaureateEmpathyFemaleHealth Knowledge, Attitudes, PracticeHemophilia AHomosexuality, MaleHumansMalePrejudiceStudents, NursingSubstance Abuse, IntravenousJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Ward. 1998. Caring by degrees.. https://doi.org/10.5172/conu.1998.7.1.24

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.

The heterozygous 32 base pair deletion of the chemokine receptor 5 (Delta32CCR5) has been associated with a more benign course of HIV-1-infection. To study the influence of Delta32CCR5 on the response to antiviral therapy we analyzed the presence of Delta32CCR5 by PCR in PBMC from 107 randomly selected HIV-1-infected patients treated with HAART for at least three months. 24 of 107 patients were heterozygous for Delta32CCR5 (22.4%). Before initiation of HAART Delta32CCR5 heterozygous patients (d/w) did not differ from homozygous CCR5 wild-type patients (w/w) regarding viral load and CD4 counts. After a median treatment time on HAART of 17.5 months (d/w, range 6-31 months, p = n.s.) or 19 months (w/w, range 3-33 months) all 24 patients (100%) with the Delta32CCR5 mutation, but only 58/83 patients (69.9%) with wild-type CCR5 showed a suppression of HIV-1-viremia below 500 copies/ml (p = 0.0020). Furthermore, 20/24 (83.3%) of the Delta32CCR5 heterozygous patients achieved CD4 counts above 200/microliter, but only 57/83 (68.7%) of the patients homozygous for CCR5 wild-type (p = 0.011). Our data indicate that the presence of heterozygous Delta32CCR5 is associated with a better response to HAART suggesting that therapeutic strategies targeting CCR5 could be of value for a sustained suppression of HIV-1 by HAART.

Acquired Immunodeficiency Syndrome↗
PubMed2000

Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro.

Dendritic cells (DCs) genetically modified to continually express and present antigens may be potent physiologic adjuvants for induction of prophylactic or therapeutic immunity. We have previously shown that an env and nef deleted HIV-1 vector (HIV-1 delta EN) pseudotyped with VSV-G transduced monocyte-derived macrophages as well as CD34(+) precursors of DCs. Here we extended these findings with HIV-1 delta EN to highly differentiated human DCs derived in culture from circulating monocytes (DCs). In addition, a new vector derived from HIV-1 delta EN but further deleted in its remaining accessory genes vif, vpr, and vpu (HIV-1 delta EN V(3)) was also tested. Both vectors efficiently transduced DCs. Transduction of DCs did not significantly alter their viability or their immunophenotype when compared with untransduced DCs. Furthermore, the phagocytic potential of immature DCs, as well as their ability to differentiate into mature DCs capable of stimulating T-cell proliferation, was not affected. Finally, DCs transduced by the HIV-1 delta EN vector were able to elicit a primary antiviral cytotoxic T-cell response in autologous CD8 T cells. These results suggest that HIV-1-based vectors expressing viral antigens may be useful for in vivo active immunization as well as ex vivo priming of cytotoxic T cells for adoptive T-cell therapy. (Blood. 2000;96:1327-1333)

Acquired Immunodeficiency Syndrome↗